🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00602199
The primary objective of this study is to assess the safety and effectivene...
Status
Completed
Location
Hematology Oncology Associates
Start Date
2003-04
Trial ID
NCT00061672
Treatments Being Tested
The primary objective of this study is to determine the recommended Phase I...
Status
Completed
Location
Duke University Medical Center
Start Date
2005-09
Trial ID
NCT00586092
Treatments Being Tested
The primary objective of this study is to assess the safety and effectivene...
Status
Completed
Location
Virginia G. Piper Cancer Center
Start Date
2003-05
Trial ID
NCT00061659
Treatments Being Tested
To determine the maximum tolerated dose of ABT 510 when administered concur...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2003-08
Trial ID
NCT00584883
Treatments Being Tested
The goals of this clinical research study are to see how individuals with a...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2005-04
Trial ID
NCT00113334
Treatments Being Tested
The primary objective of this Phase II study is to assess the safety, pharm...
Status
Terminated
Location
Oncology-Hematology Group of South Florida
Start Date
2003-03
Trial ID
NCT00061646
Treatments Being Tested
The primary objective of this study is to assess the safety and efficacy of...
Status
Completed
Location
Virginia G. Piper Cancer Center
Start Date
2003-05
Trial ID
NCT00073125
Treatments Being Tested